Social Adversity Tied to Worse Mortality in PH

You May Be Interested In:Accelerated Approval of New TKI Use in CML Sparks Questions


BOSTON — Social adversity is associated with worse survival among patients with pulmonary hypertension (PH), according to a new retrospective study of a New York City population. Among patients with HIV with heart failure, PH was associated with about a threefold increase in all-cause mortality, but that risk increased to about sevenfold when social adversity, identified by a licensed social worker, was also present.

A sub-analysis of both patients with HIV and those without HIV showed worse mortality outcomes with social adversity in both groups.

“Almost the majority of patients that we treat have either some social adversity or no insurance or are undocumented, so as a group of residents, we decided to study the impact of these factors on their health and the care that can be provided. We started using the two cohorts and now we keep it going with every new resident,” said Luca Biavati, MD, who presented the study at the American College of Chest Physicians (CHEST) 2024 Annual Meeting.

“The presence of any form of socioeconomic disadvantage is negatively impacting care and for a large part of the population, there are some factors that could probably be addressed by either an institutional or hospital policy,” said Biavati, who is an internal medicine resident at Jacobi Medical Center, Bronx, New York.

Other factors are more difficult to address, such as lack of education. “[Some patients] don’t understand the gravity of their issue and medical condition until it’s too late, and then they’re not fit enough for the treatment, or just because of the social situation, they cannot qualify for advanced therapies,” said Biavati.

The researchers established two cohorts: One consisting of patients with HIV and heart failure who may or may not have had PH and one comprising patients with PH with or without HIV and heart failure. In the HIV/heart failure group, PH without social adversity was associated with a nearly threefold increase in all-cause mortality (hazard ratio [HR], 2.83; P = .004), whereas PH with social adversity was linked to a more than sevenfold increase in all-cause mortality (HR, 7.14; P

Within the PH cohort, social adversity was associated with lower survival (P P = .040), transportation issues within the HIV− population (HR, 12.8; P P P = .028). 

The research has prompted interventions, which are now being studied at the institution, according to Biavati. “We have a policy of giving medications in bags when we discharge a patient with a social adversity. We literally go to the pharmacy, bring up the bag of medication, and we [put it] in their hands before they leave the hospital. They get a 1 or 3 months’ supply, depending on the medication, and then we usually discharge them with a clinical appointment already scheduled with either a pulmonary or primary care provider, and we usually call them before every appointment to confirm that they’re coming. That increases the chances of some success, but there’s still a very long way to go,” said Biavati.

Biavati was blinded to the results of the intervention, so he could not report on whether it was working. “But I can tell you that I’ve had busier clinics, so hopefully that means that they’re showing up more,” he said.

The problem is complex, according to Sandeep Jain, MD, who moderated the session. “Social adversity means lack of education. Lack of education means lack of compliance. Lack of compliance means what can you do if people are not taking medications? So it’s all matched together. It’s all lack of education and lack of money, lack of family support. And these drugs they have to take every single day. It’s not that easy. It’s very easy for us to say I had antiretroviral treatment for 6 months. It is almost impossible to continue regular treatment for that long [for a patient with social adversity]. You can’t blame them if they aren’t taking treatments. It’s very difficult for them,” said Jain.

That underscores the need for interventions that can address the needs of patients with social adversity. “We have to [practice] medicine considering the social situation of the patient and not just the medicine that we study in books. That’s kind of what we are faced with every day. We have therapies, and then life happens. It’s much harder to care for those patients,” said Biavati.

Biavati and Jain reported no relevant financial relationships.

Jim Kling is a writer in Bellingham, Washington.

share Paylaş facebook pinterest whatsapp x print

Similar Content

A photo of a female healthcare worker vaccinating a woman.
ACIP Backs Extra COVID Vax Dose for Seniors, Pneumococcal Vax for Adults 50 and Up
A computer rendering of monoclonal antibodies attacking thyroid cancer.
Precision Medicine Approach Shows Promise for Anaplastic Thyroid Cancer
How Immigrant Advocates are Preparing for Trump's Return 
How Immigrant Advocates are Preparing for Trump’s Return 
Synergy of Combination Therapy for NSCLC Brain Metastases?
Synergy of Combination Therapy for NSCLC Brain Metastases?
Crackdown on Homeless Encampments Raises Public Health Questions - KFF Health News
Tribal Leaders Ask Feds To Declare Syphilis Outbreak a Public Health Emergency – KFF Health News
British Lawmakers Vote in Favor of Legalizing Assisted Dying
British Lawmakers Vote in Favor of Legalizing Assisted Dying
Today's Insight | © 2024 | News